Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anfoxacin vs levofloxacin for pyelonephritis (phase 2, China)
CTR20160239Phase 2Active
- Sponsor
- Anhui Global Pharmaceutical Co., Ltd.
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anfoxacin in pyelonephritis, sponsored by Anhui Global Pharmaceutical Co., Ltd.. Started Jun 2016; status: active.
02
Drugs
anfoxacin
03
Conditions
pyelonephritis
Beyond the preview
Go deeper on CTR20160239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160239.